These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36061570)

  • 1. Antimicrobial use and aetiology of bloodstream infections in critically ill patients during early stages of SARS-CoV-2 pandemic.
    Torrecillas M; Gumucio VD; Padullés A; Tubau F; Marco D; Shaw E; Fernández-Huerta M; Maisterra K; Grau I; Petito MM; Berbel D; Puig-Asensio M; Pérez XL; Domínguez MÁ; Sabater J; Ardanuy C; Càmara J
    Infect Prev Pract; 2022 Dec; 4(4):100241. PubMed ID: 36061570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bloodstream infections in the era of the COVID-19 pandemic: Changing epidemiology of antimicrobial resistance in the intensive care unit.
    Ntziora F; Giannitsioti E
    J Intensive Med; 2024 Jul; 4(3):269-280. PubMed ID: 39035613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Impact of COVID-19 on Multi-Drug-Resistant Gram-Negative Bacilli Bloodstream Infections in an Intensive Care Unit Setting: Two Pandemics Compared.
    Cogliati Dezza F; Arcari G; Alessi F; Valeri S; Curtolo A; Sacco F; Ceccarelli G; Raponi G; Alessandri F; Mastroianni CM; Venditti M; Oliva A
    Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of COVID-19 pandemic on healthcare-associated infections, antibiotic resistance and consumption rates in intensive care units.
    Önal U; Tüzemen Ü; Kazak E; Gençol N; Souleiman E; İmer H; Heper Y; Yılmaz E; Özakın C; Ener B; Akalin H
    Infez Med; 2023; 31(2):195-203. PubMed ID: 37283640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital-Acquired Infections in Critically Ill Patients With COVID-19.
    Grasselli G; Scaravilli V; Mangioni D; Scudeller L; Alagna L; Bartoletti M; Bellani G; Biagioni E; Bonfanti P; Bottino N; Coloretti I; Cutuli SL; De Pascale G; Ferlicca D; Fior G; Forastieri A; Franzetti M; Greco M; Guzzardella A; Linguadoca S; Meschiari M; Messina A; Monti G; Morelli P; Muscatello A; Redaelli S; Stefanini F; Tonetti T; Antonelli M; Cecconi M; Foti G; Fumagalli R; Girardis M; Ranieri M; Viale P; Raviglione M; Pesenti A; Gori A; Bandera A
    Chest; 2021 Aug; 160(2):454-465. PubMed ID: 33857475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial use and mortality among intensive care unit patients with bloodstream infections: implications for stewardship programs.
    Ababneh MA; Al Domi M; Rababa'h AM
    Heliyon; 2022 Aug; 8(8):e10076. PubMed ID: 35982844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network.
    Buetti N; Ruckly S; de Montmollin E; Reignier J; Terzi N; Cohen Y; Siami S; Dupuis C; Timsit JF
    Intensive Care Med; 2021 Feb; 47(2):180-187. PubMed ID: 33506379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical profile of bloodstream infections in COVID-19 patients: a retrospective cohort study.
    Palanisamy N; Vihari N; Meena DS; Kumar D; Midha N; Tak V; Sharma A; Bohra GK; Kothari N; Dutt N; Bhatia PK; Garg MK; Misra S
    BMC Infect Dis; 2021 Sep; 21(1):933. PubMed ID: 34496787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of the COVID-19 Pandemic on Antimicrobial Resistance and Management of Bloodstream Infections.
    Petrakis V; Panopoulou M; Rafailidis P; Lemonakis N; Lazaridis G; Terzi I; Papazoglou D; Panagopoulos P
    Pathogens; 2023 May; 12(6):. PubMed ID: 37375470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between COVID-19 and ICU-Acquired Bloodstream Infections Related to Multidrug-Resistant Bacteria.
    Piantoni A; Houard M; Piga G; Zebian G; Ruffier des Aimes S; Holik B; Wallet F; Rouzé A; Kreitmann L; Loiez C; Labreuche J; Nseir S
    Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bloodstream Infections in Intensive Care Unit during Four Consecutive SARS-CoV-2 Pandemic Waves.
    Pozza G; Casalini G; Ciubotariu CL; Giacomelli A; Galimberti M; Zacheo M; Rabbione A; Pieruzzi M; Oreni L; Galimberti L; Colombo R; Rizzardini G; Pagani C; Rimoldi SG; Bonazzetti C; Ridolfo AL; Antinori S
    Antibiotics (Basel); 2023 Sep; 12(9):. PubMed ID: 37760744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in the frequency of catheter-related bloodstream infections during the COVID-19 pandemic: a plea for control.
    Pérez-Granda MJ; Carrillo CS; Rabadán PM; Valerio M; Olmedo M; Muñoz P; Bouza E
    J Hosp Infect; 2022 Jan; 119():149-154. PubMed ID: 34627934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the Pandemic Outbreak on ICU-Associated Infections and Antibiotic Prescription Trends in Non-COVID19 Acute Respiratory Failure Patients.
    Bussolati E; Cultrera R; Quaranta A; Cricca V; Marangoni E; La Rosa R; Bertacchini S; Bellonzi A; Ragazzi R; Volta CA; Spadaro S; Scaramuzzo G
    J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the Pendulum of Antimicrobial Drug Resistance Swinging Back after COVID-19?
    Serapide F; Quirino A; Scaglione V; Morrone HL; Longhini F; Bruni A; Garofalo E; Matera G; Marascio N; Scarlata GGM; Cicino C; Russo A; Trecarichi EM; Torti C
    Microorganisms; 2022 May; 10(5):. PubMed ID: 35630400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections.
    Gaspari R; Spinazzola G; Teofili L; Avolio AW; Fiori B; Maresca GM; Spanu T; Nicolotti N; De Pascale G; Antonelli M
    Eur J Clin Invest; 2021 Dec; 51(12):e13687. PubMed ID: 34599600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bloodstream infections in the COVID-19 era: results from an Italian multi-centre study.
    Pasquini Z; Barocci I; Brescini L; Candelaresi B; Castelletti S; Iencinella V; Mazzanti S; Procaccini G; Orsetti E; Pallotta F; Amadio G; Giacometti A; Tavio M; Barchiesi F
    Int J Infect Dis; 2021 Oct; 111():31-36. PubMed ID: 34416402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance in intensive care patients hospitalized with SEPSIS: a comparison between the COVID-19 pandemic and pre-pandemic era.
    Falasca K; Vetrugno L; Borrelli P; Di Nicola M; Ucciferri C; Gambi A; Bazydlo M; Taraschi G; Vecchiet J; Maggiore SM
    Front Med (Lausanne); 2024; 11():1355144. PubMed ID: 38813381
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Rangel K; Chagas TPG; De-Simone SG
    Pathogens; 2021 Aug; 10(8):. PubMed ID: 34451470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surging bloodstream infections and antimicrobial resistance during the first wave of COVID-19: a study in a large multihospital institution in the Paris region.
    Amarsy R; Trystram D; Cambau E; Monteil C; Fournier S; Oliary J; Junot H; Sabatier P; Porcher R; Robert J; Jarlier V;
    Int J Infect Dis; 2022 Jan; 114():90-96. PubMed ID: 34688945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and prognosis of bloodstream infection in patients with COVID-19 admitted in the ICU: an ancillary study of the COVID-ICU study.
    Massart N; Maxime V; Fillatre P; Razazi K; Ferré A; Moine P; Legay F; Voiriot G; Amara M; Santi F; Nseir S; Marque-Juillet S; Bounab R; Barbarot N; Bruneel F; Luyt CE;
    Ann Intensive Care; 2021 Dec; 11(1):183. PubMed ID: 34952960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.